申请人:Nihon Medi-Physics Co., Ltd.
公开号:US08303935B2
公开(公告)日:2012-11-06
The present invention provides a compound which has affinity with amyloid, shows sufficiently rapid clearance from normal tissues and is suppressed in toxicity such as mutagencity. Provided is a compound represented by the following formula (1) or a salt thereof:
wherein A1, A2, A3 and A4 independently represents a carbon or nitrogen; R1 is a halogen substituent; R2 is a halogen substituent; and m is an integer of 0 to 2, provided that at least one of R1 and R2 is a radioactive halogen substituent, at least one of A1, A2, A3 and A4 represents a carbon, and R1 binds to a carbon represented by A1, A2, A3 or A4 as well as a low-toxic diagnostic agent comprising a compound represented by the preceding formula or a salt thereof.
本发明提供了一种与淀粉样蛋白亲和力强,从正常组织中清除速度足够快且毒性抑制,例如突变性的化合物。提供了一种由以下式(1)或其盐所表示的化合物:其中A1、A2、A3和A4独立地代表碳或氮;R1是卤素取代基;R2是卤素取代基;m是0到2的整数,前提是R1和R2中至少有一个是放射性卤素取代基,A1、A2、A3和A4中至少有一个代表碳,R1结合到由A1、A2、A3或A4所代表的碳,以及包含上述式或其盐所表示的低毒诊断剂的方法。